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Abstract
Domestic poultry serve as intermediates for transmission of influenza A virus from the wild
aquatic bird reservoir to humans, resulting in influenza outbreaks in poultry and potential ep-
idemics/pandemics among human beings. To combat emerging avian influenza virus, an in-
expensive, heat-stable, and orally administered influenza vaccine would be useful to
vaccinate large commercial poultry flocks and even migratory birds. Our hypothesized vac-
cine is a recombinant attenuated bacterial strain able to mediate production of attenuated
influenza virus in vivo to induce protective immunity against influenza. Here we report the
feasibility and technical limitations toward such an ideal vaccine based on our exploratory
study. Five 8-unit plasmids carrying a chloramphenicol resistance gene or free of an antibi-
otic resistance marker were constructed. Influenza virus was successfully generated in
avian cells transfected by each of the plasmids. The Salmonella carrier was engineered to
allow stable maintenance and conditional release of the 8-unit plasmid into the avian cells
for recovery of influenza virus. Influenza A virus up to 107 50% tissue culture infective doses
(TCID50)/ml were recovered from 11 out of 26 co-cultures of chicken embryonic fibroblasts
(CEF) and Madin-Darby canine kidney (MDCK) cells upon infection by the recombinant Sal-
monella carrying the 8-unit plasmid. Our data prove that a bacterial carrier can mediate gen-
eration of influenza virus by delivering its DNA cargoes into permissive host cells. Although
we have made progress in developing this Salmonella influenza virus vaccine delivery sys-
tem, further improvements are necessary to achieve efficient virus production, especially in
vivo.
Introduction
Influenza viruses belong to the family Orthomyxoviridae and contain single-stranded segment-
ed RNA genomes. They are classified into types A, B, and C based on the serological differences
PLOSONE | DOI:10.1371/journal.pone.0119041 March 5, 2015 1 / 20
OPEN ACCESS
Citation: Zhang X, Kong W, Wanda S-Y, Xin W,
Alamuri P, Curtiss R III (2015) Generation of Influenza
Virus from Avian Cells Infected by Salmonella
Carrying the Viral Genome. PLoS ONE 10(3):
e0119041. doi:10.1371/journal.pone.0119041
Academic Editor: Mirco Schmolke, University of
Geneva, SWITZERLAND
Received: October 25, 2014
Accepted: January 9, 2015
Published: March 5, 2015
Copyright: © 2015 Zhang et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are
credited.
Data Availability Statement: All relevant data are
within the paper.
Funding: This work was supported by grants from
the National Institutes of Health (AI065779). The
funders had no role in study design, data collection
and analysis, decision to publish, or preparation of
the manuscript.
Competing Interests: The authors declare that no
competing interests exist.
in the nucleoproteins (NP) and matrix proteins [1]. Unlike type B and C influenza viruses
which infect very limited species [2,3], influenza A virus has a broad host range including hu-
mans, avian species, and a diversity of mammals [4–6]. As of today, influenza A virus with all
hemagglutinin/neuraminidase (HA/NA) combinations are found in aquatic bird reservoirs
[4,7]. Without causing apparent signs of disease (except some H5N1 strains), the virus repli-
cates in the respiratory and intestinal tracts of the aquatic birds [8,9], where the cells mainly ex-
press α2–3 linked sialic acid (SA) receptors [10]. After being excreted in high concentration in
the feces, influenza A virus remains infectious in lake water for up to 4 days at 22°C and more
than 30 days at 0°C [11]. Backyard poultry have chance to contact with migratory birds, occa-
sionally become infected through the fecal-oral route and introduce new “foreign” influenza vi-
ruses [12–14]. The foreign virus therefore causes an outbreak among immunologically naïve
birds. The world-wide outbreaks of highly pathogenic avian influenza (HPAI) H5N1 have re-
sulted in death or depopulation of wild birds and poultry in hundreds of millions [15]. Addi-
tionally, the avian virus could be transmitted to humans from infected poultry at low
efficiency, such as occurred for the H5N1 avian influenza virus [16–18]. This low infectivity
was most likely because the avian virus prefers α2–3 linked SA receptors which only reside in
the less reachable lower respiratory tract of humans [19]. After adaptation in infected humans
or other mammalian hosts, the virus may acquire the ability of efficient binding to α2–6 linked
SA receptors in human trachea as the human influenza virus does [20]. Another possibility is
that an intermediary host serves as the mixing vessel [21]. For instance, pigs have α2–3 and
α2–6 linked SA receptors in the trachea [22] and is susceptible to avian and human influenza
viruses [23–25]. Dual infection with both viruses can result in reassortant viruses [26,27]. By ei-
ther way, the viruses with foreign HA become human-to-human transmissible and may result
in an epidemic or pandemic in the human population.
In numerous countries, inactivated influenza virus vaccines have been used to combat the
highly and low pathogenic avian influenza viruses [28–33]. Such measures not only benefit the
poultry and egg industry but also prevent virus transmission to humans. However,
manufacturing the current veterinary influenza vaccine relies on healthy chicken embryos [33].
Administration of the vaccine by subcutaneous or intramuscular injection is costly and labor-
intensive, and thus is not ideal for vaccinating large commercial flocks and wild birds, leaving
slaughter of infected poultry as the viable option to control the spread of avian influenza.
Live bacterial vaccines are effective, safe, inexpensive, and can be rapidly produced in large
quantities [34,35]. The other distinctive feature is immunization via the oral or intranasal
routes, thus reducing the operational costs involved in administering injectable vaccines. Sal-
monella is one of the most promising bacterial vectors that can deliver target protective anti-
gens through the host mucosa [36]. Numerous technologies have been developed over the
years to make more safe and effective Salmonella vectors for various applications, such as pro-
grammed Salmonella lysis for delivery of protein or plasmid cargoes [37–39], balanced lethal
systems for Salmonella to harbor plasmid free of antibiotic resistance genes [40–45], regulated
delayed in vivo attenuation [46,47], and recA or recF deletion to stabilize plasmids containing
repetitive sequences [48]. On the other side, we had created an 8-unit plasmid that encodes
vRNAs and proteins for assembling influenza virus in avian cells [46]. In this study we integrat-
ed the Salmonella delivery methodology with the pure DNA based-reverse genetics of influenza
virus [49,50]. Several recombinant attenuated Salmonella strains were generated to stably har-
bor and deliver the 8-unit plasmid into the host cells to recover influenza virus as illustrated in
Fig. 1. Our data shed light on the development of a novel vaccine composition to protect
against influenza virus in humans and domestic animals as well as in wild birds.
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Materials and Methods
Materials
The 8-unit plasmid pYA4519 carrying all genes of influenza A virus (A/WSN/33) was de-
scribed previously [51]. S. Typhimurium UK-1 strains χ3761, χ8276, χ8901, χ9052 and χ9909
were from the χ collection in the Curtiss laboratory. Plasmids pYA4784 and pYA3600 were
from Curtiss lab plasmid stock. The E. coli recAmutant strain was purchased from Epicentre
Biotechnologies (Madison, WI). All plasmids and bacterial strains used in this study are listed
in Table 1. The primers used for plasmid construction are listed in Table 2. The specific patho-
gen-free (SPF) chicken embryonated eggs were purchased from Charles River Laboratories
(Wilmington, MA). Madin-Darby canine kidney (MDCK) cells were purchased from ATCC.
Plasmid construction
The 8-unit plasmid pYA4519 (Table 1) was first linearized with SrfI and treated with calf intes-
tinal alkaline phosphatase (CIAP). Simian virus 40 (SV40) DNA nuclear targeting sequence
(DTS) was amplified from plasmid pBICEP-CMV3 (Sigma-Aldrich) with primers P1 and P2
(Table 2). The amplified DNA fragment was treated with T4 polynucleotide kinase (T4 PNK)
and ligated into SrfI/CIAP pretreated pYA4519, resulting in plasmid pYA4537. To construct
plasmid pYA4562, the kanamycin resistance gene (kan) together with its promoter was ampli-
fied from plasmid p15A-PB2-kan with primers P3 and P4. SV40 DTS was amplified from
Fig 1. Schematic representation of recombinant Salmonella-mediated generation of influenza virus. A recombinant attenuated Salmonella strain
carrying the 8-unit plasmid invades host cells and stays in the Salmonella-containing vacuole (SCV). Due to the lack of essential supplements (e.g. DAP or D-
alanine) for cell wall synthesis, the replicating bacteria undergo cell wall-impaired lysis. The plasmid is released and translocated into the host cell nucleus,
where it serves as a template for the transcription of vRNAs (whole genomic set) and mRNAs (for PB1, PB2, PA and NP). The mRNAs are translated into
proteins to bind vRNAs to form the complete set of RNPs. RNPs direct the synthesis of cRNAs, which in turn serve as templates for vRNA production. RNPs
also direct the synthesis of mRNAs for HA, NA, M and NS in addition to mRNAs for polymerase and the NP. The nascent HA, NA and M2 target the host cell
membrane. The resulting new virus buds from the host cell and is capsulated with membrane embedded with HA, NA and M2.
doi:10.1371/journal.pone.0119041.g001
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pBICEP-CMV3 with primers P5 and P6. Both amplicons were fused by a third PCR using primers
P3 and P6. The kan-DTS fusion was further amplified with primers P3 and P7. A synthetic NF-
κB binding site in plasmid pYA4545 was amplified with primers P8 and P9. The two fragments
were fused by PCR with primers P3 and P9 to obtain a fusion product kan-DTS-NFκB, which was
treated with T4 PNK and inserted into SrfI/CIAP pretreated pYA4519 to obtain pYA4562.
To eliminate the need for any antibiotic resistance markers, a DNA fragment containing the
asd gene and pBR ori was amplified from plasmid pYA3342 (Table 1) with primers P10 and
P11 (Table 2). The PCR product was digested with NgoMIV and AsiSI, and ligated into
pYA4562 treated by the same enzymes to replace the region containing the p15A ori, kan and
chloramphenicol resistance gene (cat). The resulting plasmid was designated pYA4920. Simi-
larly, a DNA fragment containing the aroA gene and p15A ori was amplified from plasmid
pYA4784 with primers P12 and P13, digested with XmaI and AsiSI, then inserted between the
NgoMIV (produces compatible end with XmaI-digested DNA) and AsiSI sites in pYA4562 to
Table 1. Plasmids and bacterial strains used in the study.
Plasmid/strain Description/genotype* Source or reference
Plasmids
pBICEP-CMV3 pBR ori, bla, SV40 DTS Sigma-Aldrich
p15A-PB2-kan p15A ori, cat, kan, influenza PB2 [46]
pYA3342 pBR ori, asd [54]
pYA4336 CMV-driven EGFP gene This work
pYA4731 CMV-driven mCherry gene [46]
pYA4545 pUC ori, asd, NF-κB binding site [37]
pYA4784 p15A ori, aroA Lab stock
pYA4519 p15A ori, cat, 8-unit [46]
pYA4537 p15A ori, cat, 8-unit, SV40 DTS This work
pYA4562 p15A ori, cat, 8-unit, SV40 DTS, NF-κB binding site This work
pYA4913 p15A ori, cat, 7-unit (ΔHA) This work
pYA4732 p15A ori, cat, 8-unit, CMV-driven mCherry gene [46]
pYA4920 pBR ori, asd, 8-unit, SV40 DTS, NF-κB binding site This work
pYA4954 p15A ori, aroA, 8-unit, SV40 DTS, NF-κB binding site This work
pYA3600 ΔaroA suicide vector Lab stock
Salmonella
strains
χ3761 wild type [88]
χ9909 ΔaroA χ collection
χ8276 Δasd [38]
χ8901 Δalr ΔdadB [89]
χ9052 Δalr ΔdadB Δasd [89]
χ9834 Δalr ΔdadB Δasd ΔrecA This work
χ11018 Δalr ΔdadB Δasd ΔrecF This work
χ11150 Δalr ΔdadB Δasd ΔrecF ΔaroA This work
E. coli strain
EPI300 F− mcrA Δ(mrr-hsdRMS-mcrBC) Φ80dlacZ ΔM15 ΔlacX74 recA1 endA1 araD139 Δ(ara, leu)7697 galU galK
λ− rpsL nupG trfA dhfr
Epicentre
Biotechnologies
* bla: ampicillin resistance gene;
cat: chloramphenicol resistance gene; kan: kanamycin resistance gene. ΔaroA: PABA and DHBA dependent; Δasd: DAP dependent; Δalr ΔdadB (also
called dadX): D-alanine dependent; ΔrecA: reduce plasmid recombination; ΔrecF: reduce plasmid recombination.
doi:10.1371/journal.pone.0119041.t001
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replace the p15A ori, kan and cat. The resulting plasmid was called pYA4954. To construct
plasmid pYA4913, the kan cassette was amplified from plasmid p15A-PB2-kan with primers
P14 and P15. The amplified kan cassette was trimmed by NgoMIV and PmlI, and ligated into
pYA4519 digested by same enzymes to replace the HA cassette. The resulting 7-unit plasmid
pYA4913 (ΔHA) was used as a control. During plasmid construction, large DNA fragments
were separated on agarose gels containing 10 μg/ml crystal violet and excised under bright
room light [52]. The E. coli recAmutant strain was used for all DNA cloning experiments. Plas-
mid DNA was prepared using Mini and Maxi plasmid preparation kits (Qiagen).
Strain construction and growth conditions
Each strain was cultured in LB broth with complementary supplements, such as 50 μg/ml dia-
minopimelic acid (DAP,) or 100 μg/ml DL-alanine. Strain χ9834 was generated from χ9052 by
deleting the recA gene using Lambda Red recombinase-mediated recombination [53]. Strain
χ11018, another χ9052-derivative, was created by deleting the recF gene using P22HTint-medi-
ated transduction [54]. Suicide vector pYA3600 contains aroA-flanking regions from S. Typhi-
murium was designed to enable a 1296 bp in-frame-deletion of aroA ORF (aroA-12 to 1284)
(Table 1). S. Typhimurium strain χ9909 was generated from the wild-type S. Typhimurium
strain χ3761 using suicide vector pYA3600. Strain χ11018 was transduced with P22 lysates
(χ9909::pYA3600) to delete the aroA gene [54]. The resulting strain was designated χ11150.
Conditional growth of the strains was tested on LB agar plates supplemented with or without
50 μg/ml DAP and/or 100 μg/ml DL-alanine. It is worth noting that electroporation was em-
ployed to introduce plasmid and DNA fragment into Salmonella strains.
Cell culture
Chicken embryonic fibroblasts (CEF) were prepared from 8-day-old SPF chicken embryos
using 0.25% trypsin-EDTA. To passage the CEF, 0.05% trypsin-EDTA was used for digestion.
Table 2. Primers used in this study.
Primer Sequence (50!30)* Enzyme site
P1 tgcgatcgctgtggaatgtgtgtcagttaggg AsiSI
P2 accttgatcaggagctttttgcaaaagcctagg EcoNI
P3 ccggaattgccagctggggc
P4 actgacacacattccacagcgatcgctccgcgcacatttccccg AsiSI
P5 cggggaaatgtgcgcggagcgatcgctgtggaatgtgtgtcagt AsiSI
P6 accttgatcaggagctttttgcaaaagcctaggc EcoNI
P7 cccgtaattgattactattgcggagttaggggcgggac
P8 gtcccgcccctaactccgcaatagtaatcaattacggg
P9 accttgatcaggcggaactccatatatggg EcoNI
P10 taagccggctccaacatcacaggtaaacag NgoMIV
P11 ttagcgatcgccggaagatccgcacatctct AsiSI
P12 taacccggggcgctagcggagtgtatac XmaI
P13 ttagcgatcgcggctaaacgcgttgtttaac AsiSI
P14 taagccggcccggaattgccagctggggc NgoMIV
P15 ttacacgtgtccgcgcacatttccccgaaaag PmlI
* The restriction enzyme sites in primers are underlined.
doi:10.1371/journal.pone.0119041.t002
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CEF and MDCK cells were maintained in Dulbecco's modified Eagle's medium (DMEM, Invi-
trogen, Cat. 11885) supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin and
100 μg/ml streptomycin. To co-culture CEF and MDCK cells, each type of nearly confluent
cells grown in 75 cm2 flasks were first treated with trypsin. Then, 1/4 volume of MDCK cells
were mixed with 1/6 volume of CEF. Growth medium was added to a total volume of 20 ml.
The mixed cells were seeded into six-well plates (3 ml per well) and maintained at 37°C in 5%
CO2. At all times, Salmonella strains were incubated with co-cultured cells in absence of peni-
cillin and streptomycin.
Virus generation via DNA transfection
To ascertain that the newly constructed plasmids are enable to recover influenza virus in avian
cells, the co-culture of CEF and MDCK cells grown in 6-well plates were transfected using cat-
ionic lipids (Invitrogen, Cat. 11668019) according to the vendor’s instructions. Briefly, 2 μl of
transfection reagent per μg plasmid DNA were individually diluted in 100 μl of minimal essen-
tial medium (MEM, Invitrogen, Cat. 31985088). After 5 min incubation at room temperature
(RT), the diluted transfection reagent was mixed with the DNA, followed by 40 min incubation
at RT. The transfection mixture was added to pre-washed eukaryotic cells drop by drop. After
3 h incubation, the transfection medium was replaced with 2 ml of MEM containing 0.3% bo-
vine serum albumin (BSA), penicillin and streptomycin. At one day post transfection, each
well was supplemented with 1 ml of MEM containing 2 μg/ml TPCK-trypsin, 0.3% BSA, peni-
cillin and streptomycin. At three to five days post transfection, cell supernates were titrated
onto MDCK cell monolayers to estimate influenza virus titers. The rescued influenza viruses
were confirmed by hemagglutination assays [55], and by western blot with influenza A virus
NP or M2-specific antibodies.
Conditional destruction of Salmonella vectors
Each strain was grown in 5 ml of LB broth with complimentary supplement(s) at 30°C over-
night. To determine Salmonella lysis in absence of necessary supplement(s), 1 ml of the over-
night culture was pelleted and resuspended in 1 ml of LB broth. 200 μl of resuspended bacteria
was transferred into 5 ml of LB broth. After overnight standstill incubation at 37°C, 1 ml of the
culture was pelleted at 8,000 rpm for 5 min and resuspended in 50 μl of 1% NaCl. Live and
dead bacteria were determined by differential staining using the bacterial viability kit (Life
Technologies, Cat. L34856) followed by microscopy. Propidium iodide (PI) and green fluores-
cent nucleic acid stain were dissolved into 5 ml of 1% NaCl to prepare 2 × staining solution as
described in the kit manual. Resuspended Salmonella cells were mixed with an equal volume of
2 × staining solution and incubated at RT for 15 min. Then, 5 μl of the stained bacteria were
mixed with 5 μl of 37°C pre-warmed 1.0% low melting agarose (Sigma-Aldrich, Cat. A5030) in
1% NaCl. Immediately, 5 μl of mixture was transferred onto the center of a slide and covered
with a coverslip. Gentle pressure was applied on the coverslip to form a thin layer of bacteria.
The slide was set aside for 20 min at RT to solidify the agarose (to stop the moving bacteria and
limit the spreading of released DNA). Bacteria were observed under a fluorescent microscope
using dsRed and GFP filters. The ratios of PI-stained cells were calculated by counting more
than 200 Salmonella cells for each strain. Chi-square tests were performed for statistical
analysis.
Salmonella-mediated plasmid delivery
S. Typhimurium strains carrying plasmid (pYA4336, pYA4731, pYA4732) were individually
cultured in 3 ml of LB broth containing 50 μg/ml DAP and/or 100 μg/ml DL-alanine, along
Salmonella-Mediated Generation of Influenza Virus
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with 100 μg/ml ampicillin or 25 μg/ml chloramphenicol to maintain the plasmid. After over-
night incubation at 30°C with vigorous shaking (200 rpm), 1 ml of the culture was harvested
by centrifugation at 12,000 rpm for 2 min and the pellet was resuspended in 1 ml of DMEM
devoid of any supplements. Plasmid pYA4336 (15 μg) was mixed with χ9052 to serve as con-
trol. CEF were washed three times with DMEM. Then, each well of cells (6-well plate) received
900 μl or 800 μl of DMEM, followed by 100 μl or 200 μl of resuspended bacteria to yield a total
volume of 1 ml. After 1 h incubation at 37°C in a 5% CO2 humidified incubator, the infection
medium was replaced with 3 ml of DMEM containing 10 μg/ml gentamicin and 10% FBS.
At one day post infection, cells were fixed with 2% paraformaldehyde (PFA) and stained with
3 μM 40,6-diamidino-2-phenylindole dihydrochloride (DAPI). Cells synthesizing enhanced
green fluorescent protein (EGFP) or red fluorescent protein (mCherry) were observed under a
fluorescence microscope, and were counted in random fields [56].
DNA recombination in Salmonella
Salmonella strains χ9052, χ9834 and χ11018 were each electroporated with plasmid pYA4519,
plated onto LB agar plates and incubated overnight at 37°C. Single colonies from each electro-
poration were individually cultured in 3 ml of LB broth and incubated at 37°C overnight with
rotary shaking. Plasmid DNA was prepared, and verified by BamHI restriction mapping. The
percentage of clones having the expected restriction pattern was calculated. Statistically signifi-
cant differences were revealed by Chi-square tests. From each strain, a correct clone was diluted
1:1000 into 3 ml of LB broth and grown at 37°C for 12 h. The dilution and growth process was
repeated for 4 additional cycles. Plasmid DNA was extracted from 1.5 ml of culture from each
cycle of growth. An aliquot of plasmid from each sample was digested with BamHI and sepa-
rated on a 1.2% agarose gel. All media were supplemented with 25 μg/ml chloramphenicol to
maintain the plasmid, 50 μg/ml DAP and 100 μg/ml DL-alanine to satisfy the growth require-
ments due to the Δasd, Δalr and ΔdadBmutations.
Virus generation via Salmonella-mediated plasmid delivery
The required strains of S. Typhimurium were each inoculated into 3 ml of LB broth containing
appropriate supplements. For χ9834 carrying pYA4519 or pYA4562, the medium was supple-
mented with 50 μg/ml DAP, 100 μg/ml DL-alanine and 34 μg/ml chloramphenicol. For
χ11150, the medium was supplemented with 50 μg/ml DAP, 100 μg/ml DL-alanine, 10 μg/ml
2,3-dihydroxybenzoic acid (DHBA), and 10 μg/ml para-aminobenzoic acid (PABA). Strain
χ11150(pYA4920) was incubated in similar medium, but without DAP. For χ11150
(pYA4954), LB broth was supplemented with 50 μg/ml DAP and 100 μg/ml DL-alanine. After
overnight incubation at 30°C with rotary shaking (200 rpm), 1 ml of the bacterial culture was
pelleted at 12,000 rpm for 2 min and resuspended into 1 ml of DMEM without any supple-
ment. 10 μg of plasmid pYA4920 was mixed with χ11150 to serve as control. The infection pro-
cess was performed as described above. At one day post infection, 1 ml of MEM containing
0.3% BSA, 10 μg/ml gentamicin and 2 μg/ml TPCK-trypsin was added to each well. At five
days post infection, the supernate was assayed for hemagglutination of 0.5% chicken red blood
cells (RBC) and titrated on MDCK cells as 50% tissue culture infective dose (TCID50). The am-
plified virus was further verified by western blot with NP or M2-specific antibodies.
Ethics Statement
The use of chicken embryonic fibroblasts did not require ethical approval.
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Results
Construction of plasmid able to generate influenza virus in avian cells
The 8-unit plasmid pYA4519 encodes the complete set of vRNAs, polymerase subunits (PB1,
PB2 and PA) and nucleoprotein (NP) of influenza WSN virus [46]. Upon transfection, this 8-
unit plasmid generates influenza virus in CEF. To achieve more efficient virus generation, we
introduced the SV40 DTS (144 bp) into plasmid pYA4519, resulting in plasmid pYA4537
(DTS, 8-unit) as illustrated in Fig. 2. The binding site for NF-κB and SV40 DTS were both in-
troduced into pYA4519 to generate plasmid pYA4562 (DTS, NF-κB, 8-unit). To eliminate the
use of antibiotics, asd and aroA genes were used as selective markers and were individually in-
troduced into pYA4562 to obtain plasmids pYA4920 (asd, DTS, NF-κB, 8-unit) and pYA4954
(aroA, DTS, NF-κB, 8-unit), respectively. The two plasmids will complement the Δasd or
ΔaroAmutation in the Salmonella carrier. The HA cassette was deleted from pYA4519 to ob-
tain plasmid pYA4913 (ΔHA, 7-unit), which serves as the negative control in virus reconstitu-
tion experiments. All resulting plasmids are listed in Table 1. To confirm that the newly
Fig 2. Construction of Asd+ and AroA+ vectors for generating influenza virus. Plasmid pYA4519 carries eight influenzaWSN virus genes, which are
individually flanked by chicken RNA polymerase I promoter (CPI) and murine RNA polymerase I terminator (MTI) to generate vRNAs. The viral polymerase
subunits (PB1, PB2 and PA) and nucleoprotein (NP) genes are further flanked with CMV promoter and bovine growth hormone gene polyadenylation
sequence (BGH) to generate mRNAs, and eventually synthesize proteins. The SV40 DTS was inserted into pYA4519 at the SrfI site to generate pYA4537. A
DNA fusion of SV40 DTS, NF-κB binding site and kan cassette was inserted into pYA4519 at the SrfI site, resulting in plasmid pYA4562. The DNA fragment
containing the asd gene and pBR ori was ligated into pYA4562 to replace the DNA fragment containing the p15A ori, cat and kan, resulting in plasmid
pYA4920. Plasmid pYA4954 was derived from pYA4562 by replacing the cat-kan fragment with the aroA cassette. The plasmid-borne asd and aroA genes
complement Δasd and ΔaroAmutations in Salmonella hosts, therefore, eliminating the use of antibiotic resistance genes. The HA cassette was deleted from
pYA4519 to generate a 7-unit plasmid pYA4913, which was used as a control. For simplicity, only plasmid pYA4519 was shown in detailed map.
doi:10.1371/journal.pone.0119041.g002
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constructed 8-unit plasmids are functional as designed, each of these plasmids was introduced
into a co-culture of CEF and MDCK cells. Of note, the MDCK cells were employed to propa-
gate influenza virus generated in and released from CEF [46]. On day 3 and day 5, viruses were
generated at the titers of 103–107 TCID50/ml (Table 3). The viruses thus generated were con-
firmed to be influenza virus by hemagglutination assay and by immunoblotting with influenza
NP or M2-specific antibodies (data not shown).
Salmonella-mediated DNA delivery into cultured avian cells
Salmonella strains χ8276 (Δasd) and χ8901 (Δalr ΔdadB) only grew on LB agar supplemented
with DAP or DL-alanine, while the strain χ9052 (Δasd Δalr ΔdadB) relied on both supplements
(Fig. 3A). To verify the conditional destruction of Salmonella strains, each strain was incubated
Table 3. Influenza virus generation from transfected MDCK-CEF co-cultures.
Plasmid Titer (TCID50/ml)
3rd day 5th day
pYA4519 1.0 × 107 3.2 × 107
pYA4537 1.0 × 106 1.0 × 108
pYA4562 3.2 × 105 3.2 × 108
pYA4920 1.0 × 104 3.2 × 107
pYA4954 3.2 × 105 3.2 × 106
pYA4913 0 0
doi:10.1371/journal.pone.0119041.t003
Fig 3. Conditional survival and DNA release from Salmonella strains. (A) Salmonella strains were streaked on LB-agar plates with or without 50 μg/ml
DAP and/or 100 μg/ml DL-alanine (D-Ala). Salmonella growth was observed after overnight incubation at 37°C. The streak order is given to the left. (B)
Overnight culture of Salmonellawas collected and resuspended in LB medium without any supplements. After overnight static growth at 37°C, cells were
stained with PI and green fluorescent nucleic acid stain. Live cells are stained green, and the dead cells are stained red. Strain number and the genotype are
given under each panel. Enlarged cell size and release of cell DNA content (indicated by arrow heads) were observed in the case of auxotrophic strains, but
not in the wild-type control strain χ3761.
doi:10.1371/journal.pone.0119041.g003
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overnight in LB broth lacking DAP and DL-alanine supplements. Green fluorescent nucleic
acid stain and PI were used to stain bacterial cells. Live cells can only be stained with green
fluorescent nucleic acid stain and exhibit green fluorescence (Fig. 3B). The impaired bacterial
membrane becomes permissible to PI, therefore, these cells are stained with green fluorescent
nucleic acid stain and PI, showing red fluorescence due to dominant PI staining. Few cells
stained yellow due to their slightly impaired membrane that allowed minute quantities of PI to
enter the cell. The yellow fluorescence was resulted from the combination of red and green
fluorescence at an appropriate ratio. Significantly higher ratios (P< 0.001) of red cells were ob-
served in the Δasdmutant (χ8276, 22.2%), the Δalr ΔdadBmutant (χ8901, 8.2%) and the Δasd
Δalr ΔdadBmutant (χ9052, 25.5%) than in wild-type strain χ3761 (2.2%), indicating mem-
brane permeability and lysis by virtue of the various mutations introduced into their genomes.
The DAP-dependent strains χ9052 (Δasd Δalr ΔdadB) and χ8276 (Δasd) showed similar per-
centages of red cells (P> 0.05), but significantly higher than the percentage of red cells shown
by the D-alanine-dependent strain χ8901 (Δalr ΔdadB) (P< 0.001). Using this protocol, some
membrane-impaired cells were also stained while they were releasing PI-bound DNA (arrow).
Empty bacterial envelopes, which have lost their DNA content, were observed in strains χ8276
(Δasd), χ8901 (Δalr ΔdadB) and χ9052 (Δasd Δalr ΔdadB) under bright field microscopy but
were not visible with the fluorescent filters (data not shown).
The intracellular delivery of plasmids was examined using different Salmonella strains. Here
we used plasmids encoding EGFP or mCherry under control of a cytomegalovirus (CMV) pro-
moter, including 6 kb plasmid pYA4336 (EGFP), 6 kb plasmid pYA4731 (mCherry), and a
25 kb plasmid pYA4732 (mCherry, 8-unit) (Table 1). Synthesis of EGFP/mCherry in avian cells
indicates the successful plasmid delivery into target cells by the Salmonella carrier. For some
reason, we consistently observed that culturing Salmonella at low temperature (RT or 30°C) in-
stead of 37°C is critical for successful plasmid delivery into cultured CEF (data not shown).
Using the protocol described in the Methods section, plasmid pYA4336 (EGFP, 6 kb) was de-
livered into CEF by each of the strains χ8276 (Δasd), χ8901 (Δalr ΔdadB) and χ9052 (Δasd
Δalr ΔdadB) as indicated by CEF synthesizing EGFP (Fig. 4). No EGFP synthesis in CEF was
observed when incubated with strain χ9052 (Δasd Δalr ΔdadB) mixed with plasmid pYA4336
(EGFP, 6 kb), suggesting that plasmid carriage by S. Typhimurium strains was required for
delivery of the plasmid into host cells. We then tested the ability of χ9834 (Δasd Δalr ΔdadB
ΔrecA) to deliver large plasmids into CEF. Two different wells of CEF were individually incu-
bated with χ9834 carrying either 6 kb plasmid pYA4731 or 25 kb plasmid pYA4732 each ex-
pressing the mCherry gene (Fig. 4, lower panel). The χ9834(pYA4731) resulted in 4.4% of
mCherry-positive CEF. Consistently, less than 10 CEF in a 10 cm2 well were found to synthe-
size mCherry after χ9834(pYA4732) infection, suggesting that the larger plasmid has limited
successful delivery into the avian cells.
Improving DNA stability in Salmonella carrier by including a recmutation
One feature of the influenza virus-generating plasmids is the presence of repetitive homologous
sequences in the promoter and the terminator elements flanking each of the viral genes
(Fig. 2). These homologous sequences form ideal substrates for DNA recombination, which
might negatively impact plasmid stability. To stabilize these plasmids in an attenuated Salmo-
nella vector, the recombinase (RecA or RecF) gene was deleted from the Rec+ strain χ9052
(Δasd Δalr ΔdadB), resulting in strains χ9834 (Δasd Δalr ΔdadB ΔrecA) and χ11018 (Δasd Δalr
ΔdadB ΔrecF). Plasmid pYA4519 was electroporated into each of the three strains. Recombina-
tion was monitored by restriction enzyme digestion of plasmid DNA isolated from different
strains. After the initial electroporation, we analyzed BamHI-digested DNA from> 50
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individual colonies from each strain. Our results (Fig. 5A) indicated that less than half of
the clones in the Rec+ strain contained plasmids with the expected restriction pattern, while
over 80% of the plasmids obtained from either the ΔrecA or ΔrecF strain remained unaltered
(P< 0.01 compared to the Rec+ strain).
A single correct colony from each electroporated strain was grown in LB broth and passaged
five times at 1000-fold dilutions. After each passage, plasmid DNA was extracted from the cul-
ture and analyzed by BamHI digestion, followed by agarose gel electrophoresis (Fig. 5B). We
noted that at time 0, before passage, the plasmid yield from the Rec+ strain (χ9052) was less
than that obtained from the two recmutants. After the second cycle of growth, there was a re-
duction in the amount of DNA in three of the expected bands, indicating that the plasmid
structure was perhaps deteriorating at each passage. Qualitative evaluation of the DNA bands
on agarose gels suggested that the plasmid structure was stable for the first four passages in
strains χ9834 (ΔrecA) and χ11018 (ΔrecF). This assay was repeated three times, and we ob-
tained consistent results each time.
Virus generation via Salmonella-mediated plasmid delivery
S. Typhimurium strain χ9834 (Δalr ΔdadB Δasd ΔrecA) carrying plasmid pYA4519 or
pYA4562 was first employed to infect co-cultures of CEF and MDCK cells. As shown in
Table 4, in five out of six wells of infected cells, the presence of influenza virus was verified by
titration on MDCK cell monolayers as well as by hemagglutination assay using chicken red
blood cells. It seemed that plasmid pYA4562 carrying the DTS and NF-κB binding site resulted
in higher titers of influenza virus than its parental plasmid pYA4519. Based on this
Fig 4. Salmonella-mediated plasmid delivery into CEF.CEF were infected with Salmonella strains each carrying a plasmid encoding EGFP or mCherry
under regulation of a CMV promoter. As a control, CEF were incubated with a mixture of χ9052 and pYA4336 DNA. At 24 h post infection, the cells were fixed
and then stained with DAPI to show the nucleus (blue). Fluorescence by EGFP (green) and mCherry (red) were recorded under a fluorescence microscope.
Strain number and the harbored plasmid are given under each panel. χ8276: Δasd; χ8901: Δalr ΔdadB; χ9052: ΔalrΔdadB Δasd; χ9834: Δalr ΔdadB Δasd
ΔrecA.
doi:10.1371/journal.pone.0119041.g004
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observation, plasmid pYA4562 was used to construct plasmids pYA4920 and pYA4954, which
are free of antibiotic resistance genes.
S. Typhimurium strain χ11150 (Δalr ΔdadB Δasd ΔrecF ΔaroA) harbors either pYA4920
(asd, DTS, NF-κB, 8-unit) or pYA4954 (aroA, DTS, NF-κB, 8-unit) to complement the ΔaroA
or Δasdmutation, respectively. Strain χ11150(pYA4920) was grown in LB medium supple-
mented with DL-alanine, DHBA and PABA, whereas strain χ11150(pYA4954) was grown in
Fig 5. Intraplasmid recombination of pYA4519. (A) Salmonella strains χ9052 (Δalr ΔdadB Δasd), χ9834 (Δalr ΔdadB Δasd ΔrecA) and χ11018 (Δalr
ΔdadB Δasd ΔrecF) were electroporated with plasmid pYA4519. Plasmid DNA from electroporants was evaluated by BamHI digestion, resulting in four DNA
fragments of 10354 bp, 7285 bp, 4013 bp, and 1966 bp from a correct plasmid. For strains χ9834 and χ11018, the percentages of correct clones are over
80%, which are significantly higher than that for parental strain χ9052 (P< 0.01, **). (B) BamHI digests of pYA4519 DNA isolated from passaged
electroporants of strains χ9052, χ9834 and χ11018. A correct clone was chosen according to the BamHI restriction map (lane 0). For each passage, bacteria
were diluted 1:1000 and cultured at 37°C for 12 h. This process was repeated for a total of five cycles. The plasmids were extracted and digested by BamHI
(lanes 1–5).
doi:10.1371/journal.pone.0119041.g005
Salmonella-Mediated Generation of Influenza Virus
PLOS ONE | DOI:10.1371/journal.pone.0119041 March 5, 2015 12 / 20
LB medium supplemented with DAP and DL-alanine. Strain χ11150 (not carrying any plas-
mid) was grown in LB medium supplemented with DAP, DL-alanine, DHBA and PABA.
Strains χ11150(pYA4920) and χ11150(pYA4954) were each incubated with co-cultures of
CEF and MDCK cells. The virus generation was verified by titration on MDCK cells and hem-
agglutination assays. For CEF/MDCK co-cultures infected with χ11150(pYA4920) and χ11150
(pYA4954), 6 out of the 20 cell supernates were detected with influenza virus with estimated ti-
ters of 107 TCID50/ml (Table 4). The hemagglutination titers ranged from 1:16 to 1:64. A mix-
ture of plasmid DNA with the Salmonella carrier (χ11150 + pYA4920) did not result in any
hemagglutination-positive or cytopathic effect (CPE)-causing cell supernate, once again con-
firming that the plasmid delivery into the eukaryotic host is Salmonella-dependent. The gener-
ated infectious particles were confirmed to be influenza A virus by western blot with NP or
M2-specific antibodies (data not shown).
Discussion
Influenza, a zoonotic disease, is one of the most serious threats to human, poultry and wild
birds worldwide. Administration of a vaccine orally or by spray could be instrumental in mass
immunization of poultry and maybe wild birds to substantially reduce the reservoir of virus in
birds, thus eventually lessening bird-to-human transmission of avian influenza virus and pre-
venting an influenza epidemic/pandemic. Currently available veterinary influenza vaccines are
not cost-effective for such a large-scale production and involve labor-intensive processes. Our
goal is to develop a bacterial-based vaccine technology that can overcome each of these limita-
tions. Briefly, an attenuated bacterial carrier delivers a target plasmid that encodes the entire
set of vRNA and proteins for assembling attenuated influenza viruses or pseudovirus particles
in the host cells. The virus generated in vivo thus serves as the vaccine to induce protective im-
munity. To examine the feasibility of developing such a technology and to identify potential
Table 4. Influenza virus generation by Salmonella-mediated plasmid delivery.
Group Dose$ Experiments (No.)
1 2 3 4 5
H Titer* H Titer H Titer H Titer H Titer
χ9834(pYA4519) 100 μl 0 0 - - - - - - - -
200 μl 0 103 - - - - - - - -
500 μl 1:2 105 - - - - - - - -
χ9834(pYA4562) 100 μl 1:16 106 - - - - - - - -
200 μl 1:4 105 - - - - - - - -
500 μl 1:8 106 - - - - - - - -
χ11150(pYA4920) 100 μl - 0 0 0 0 0 1:128 107 0 0
200 μl - 0 0 0 1:32 107 0 0 1:32 107
χ11150(pYA4954) 100 μl - 107 1:64 107 1:16 107 0 0 0 0
200 μl - 0 0 0 0 0 0 0 0 0
χ11150+pYA4920 100 μl - 0 0 0 0 0 0 0 0 0
200 μl - 0 0 0 0 0 0 0 0 0
$: represent different amount of Salmonella used for cell infection.
H: Hemagglutination assay of supernates from Salmonella-infected CEF/MDCK cell co-culture.
*: Infectious virus titer measured as TCID50/ml.
-: Not performed.
doi:10.1371/journal.pone.0119041.t004
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limiting factors in its application, we chose S. Typhimurium as the delivery vector and influen-
za WSN strain as the model virus. We had previously developed a single 8-unit plasmid that
encodes WSN viral components for virus generation [46]. In this study we delivered the plas-
mid and its derivatives into CEF using genetically modified attenuated strains of S. Typhimur-
ium and quantified the virus generated in CEF, providing initial proof-of-concept to the
hypothesized vaccine. The study also identified critical factors that limit the development of in-
fluenza vaccine based on Salmonella-mediated plasmid delivery.
Salmonella, a genus of enterobacteria, is a free-living bacterium capable of host cell invasion
[57–59], a property that was widely explored for plasmid delivery into target host cells [60].
More efficient plasmid delivery can be obtained with auxotrophic strains [61,62]. In this study
we used S. Typhimurium strains carrying loss-of-function mutation(s) in genes encoding en-
zymes critical to maintain cell wall structure or in metabolism (Table 1). The asd gene encodes
aspartate-β-semialdehyde dehydrogenase, an enzyme required for bacterial cell wall synthesis.
Inactivation of the asd gene causes an obligate requirement for DAP [63,64]. The alr and dadB
(also called dadX) genes encode alanine racemases, which are responsible for the racemization
of another key cell wall component, D-alanine [65]. Neither DAP or D-alanine are present in
LB broth, in the routinely used cell culture media or in the animal tissues, and thus require ex-
ternal supplementation. Upon deprivation of DAP or D-alanine, Salmonella strains containing
corresponding mutation(s) undergo cell wall-impaired lysis (Fig. 3). AroA is one key enzyme
in the pathway to synthesize L-tryptophan, tyrosine, phenylalanine and p-aminobenzoate [66].
Hence survival of the Salmonella strain containing ΔaroAmutation requires amino acid sup-
plements in the growth medium.
In this study, two combinations of auxotrophic mechanisms were employed to facilitate Sal-
monella-mediated delivery of the 8-unit influenza plasmids. As to χ11150-mediated delivery of
pYA4920, ΔaroA, Δalr and ΔdadB conferred auxotrophic lysis. Δasd in χ11150 was comple-
mented by the wild-type asd gene on plasmid pYA4920, ensuring the stable maintenance of the
plasmid in the Salmonella vector without the use of any antibiotics [64]. Regarding χ11150-me-
diated delivery of pYA4954, Δasd, Δalr and ΔdadB conferred cell wall-less lysis, and ΔaroA was
complemented by wild-type aroA gene in the plasmid [67]. The same mechanism was also ap-
plied to χ9834-mediated delivery of pYA4519 and pYA4562, two plasmids carrying the chlor-
amphenicol resistance gene (cat). Consistent with our previous findings [48], ΔrecA and ΔrecF
mutations significantly stabilized the 8-unit plasmids in the Salmonella delivery vector (Fig. 5).
As illustrated in Fig. 1, influenza virus was generated through Salmonella-mediated delivery of
the plasmid into co-cultured avian cells (Table 4).
To serve as a vaccine it is critical that one dose of recombinant Salmonella produce enough
quantity of attenuated influenza virus to induce protective immunity. Thanks to the immediate
propagation of the newly reconstituted viruses by MDCK cells in the co-cultures, we detected
influenza virus from 11 out of 26 CEF/MDCK co-cultures infected by recombinant Salmonella
carrying the 8-unit influenza plasmid (Table 4). However, no detectable influenza virus was re-
covered in CEF-only cultures (not co-cultured with MDCK cells) infected by the recombinant
Salmonella carrying the 8-unit plasmid (data not shown). The in vitro system could be opti-
mized to obtain consistent virus generation from infected co-cultures, but the data presented
here more realistically indicated that the current Salmonella-plasmid delivery system was not
efficient in generating influenza virus.
Certain rate-limiting steps have to be overcome before implementing this strategy for vac-
cine development. (i) Nuclear import has been appreciated as one rate-limiting step during
transfection, and was successfully overcome with small size plasmids by using nuclear localiza-
tion signal peptide [68,69] or by introducing DNA nuclear targeting sequence (DTS) and NF-
κB binding sites [70–73]. Use of SV40 DTS and NF-κB binding site slightly increased virus
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generation in Salmonella-mediated plasmid delivery (Table 4, χ9834(pYA4519) vs. χ9834
(pYA4562)). However, this effect was not seen in virus generation during transfection experi-
ments (Table 3, pYA4519 vs. pYA4562). (ii) The success of this strategy directly relies on the
plasmid delivery efficiency of the Salmonella vector. Nevertheless, the efficiency of Salmonella-
mediated delivery is low as demonstrated with the EGFP/mCherry-encoding plasmids (Fig. 4).
This limitation might be overcome by including genetic modifications that enhance Salmonella
invasion, intracellular lysis or plasmid release. Additionally, we found that only the Salmonella
vector cultured at 30°C or lower temperature instead of 37°C exhibited successful delivery of
reporter plasmids (EGFP or mCherry encoding plasmids). Understanding the mysterious
mechanism may help design a bacterial vector with higher plasmid delivery capability. (iii) Sal-
monella delivery vector should be able to efficiently invade into host cells in vivo. The current
attenuated strains of S. Typhimurium undergo direct lysis in tissue culture or in vivo upon de-
pletion of necessary supplements. After chickens were intranasally or intramuscularly infected
with Salmonella strains carrying the 8-unit plasmid, no influenza virus or influenza specific an-
tibodies were detected (data not shown). We believe that instant clearance of inoculated Salmo-
nella by the host is at least one of the governing factors.
SV40 and polio virus have been reconstituted as result of spontaneous transfer of viral ge-
nome/cDNA-containing plasmid from E. coli to cultured monkey cells [74,75]. In these studies,
virus generation are very inefficient with merely resuspended bacteria, and could be improved
by precipitating E. coli with calcium phosphate or by treating E. coli protoplasts with polyethyl-
ene glycol [74,75]. In another strategy, E. coli is engineered to express the invasin gene of Y.
pseudotuberculosis and the listeriolysin O gene of L. monocytogenes [76]. The engineered E.
coli can transfer its cargo, an artificial bacterial chromosome containing murine cytomegalovi-
rus genome (MCMV BAC), into cultured murine fibroblasts, and results in generation of
MCMV [77]. In vivo reconstitution of MCMV are achieved by injecting immunocompromised
mice with S. Typhimurium carrying MCMV BAC [78]. We engineered S. Typhimurium to
overexpress the invasin gene, aiming to arm the Salmonella vector with an additional invasion
system. However, there was no apparent improvement towards Salmonella-mediated delivery
of plasmid pYA4336 (Data not shown). Salmonella secreting listeriolysin protein or containing
sifAmutation can disrupt the phagosomal membrane, and escape into the cytoplasm [79–81].
It is reasonable to question that whether these measures could promote Salmonella-mediated
plasmid delivery.
Although bacterial vaccines have various advantages as mentioned above, biosafety con-
cerns need to be addressed. Infrequently, genes can be transmitted among bacteria through
transduction, transformation, or by conjugation. Transfer of antibiotic resistance genes may
contribute to the undesirable spread of antibiotic resistance determinants [82]. Take this into
consideration, the final vaccine will be based on the antibiotic resistance free systems, such as
using Asd+ and AroA+ as markers in the plasmids. We also attenuated the Salmonella vector
using multiple deletion mutations to prevent any phenotypic reversion. For example, the Δasd,
Δalr and ΔdadBmutations contribute to attenuation of χ11150 (pYA4954) via multiple ways,
so do the Δalr, ΔdadB and ΔaroAmutations in χ11150(pYA4920). These strains are only viable
in medium containing supplements that are unavailable in natural conditions.
We used the influenza WSN strain as a model virus in this study. For a vaccine based on
this system, the plasmid will reconstitute an attenuated or replication-deficient influenza virus
with HA and NA from a circulating influenza A virus [83–85]. Additionally, the polybasic
cleavage peptides of the HA proteins are required for high pathogenicity of influenza viruses
[4]. Thus, the polybasic cleavage site has to be eliminated during vaccine development [86,87],
to prevent formation of a new reassortant virus with the other segments from a preexisting in-
fluenza virus in the host.
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In conclusion, we prove that it is feasible to generate influenza virus through Salmonella-
mediated plasmid delivery into cultured avian cells. Whereas, further improvements are neces-
sary for the current Salmonella delivery system to achieve efficient virus recovery, a critical fac-
tor to induce protective immunity against influenza.
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